Sono-Tek (NASDAQ:SOTK) reported quarterly earnings of $0.01 per share which met the analyst consensus estimate. This is a 50 percent decrease over earnings of $0.02 per share from the same period last year.
Experimental Stem Cell Therapy For Parkinson’s Shows Promise in Phase I Trial: Reuters
In a significant development, Bayer’s (OTC:BAYRY) subsidiary BlueRock has reported initial success in treating Parkinson’s disease in humans…